Projects

Implementation and Evaluation of a Multifaceted Comprehensive Appropriate Care Package (MCACP) for People with Advanced and Terminal Illness in Intensive Care Units (ICUs) in India – A Multicentric Implementation Science Study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - 2027

Project Lead

Dr Nandini Vallath, Dr. Mathangi Krishnakumar, Dr Amarja Ashok Havaldar

Authors

Dr Nandini Vallath, Dr. Mathangi Krishnakumar, Dr Amarja Ashok Havaldar

Project Status

ongoing

Project Type

Implementation study